Adenosine Monophosphate

ectonucleoside triphosphate diphosphohydrolase 1 ; Homo sapiens







73 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34922916 Crowding within synaptic junctions influences the degradation of nucleotides by CD39 and CD73 ectonucleotidases. 2022 Jan 18 2
2 32203145 Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function. 2021 Jan 3
3 33460629 Targeting ectonucleotidases to treat inflammation and halt cancer development in the gut. 2021 May 2
4 33524787 Diabetes and hypertension: Pivotal involvement of purinergic signaling. 2021 May 1
5 33848530 ENTPD1 (CD39) Expression Inhibits UVR-Induced DNA Damage Repair through Purinergic Signaling and Is Associated with Metastasis in Human Cutaneous Squamous Cell Carcinoma. 2021 Oct 1
6 34159634 Surface AMP deaminase 2 as a novel regulator modifying extracellular adenine nucleotide metabolism. 2021 Jul 1
7 34445661 Anti-Inflammatory Effects of Endogenously Released Adenosine in Synovial Cells of Osteoarthritis and Rheumatoid Arthritis Patients. 2021 Aug 19 1
8 34571872 Thrombo-Inflammation: A Focus on NTPDase1/CD39. 2021 Aug 27 3
9 34675608 Association of the ENPP1/ENTPD1 Polymorphisms in Hemodialysis Patients. 2021 1
10 31868071 High-Throughput Screening Assays for Cancer Immunotherapy Targets: Ectonucleotidases CD39 and CD73. 2020 Mar 2
11 32133721 Depression: a new enzyme AT play. 2020 Apr 3 1
12 32614585 Discovery of AB680: A Potent and Selective Inhibitor of CD73. 2020 Oct 22 1
13 32739778 Preventing ATP Degradation by ASO-Mediated Knockdown of CD39 and CD73 Results in A2aR-Independent Rescue of T Cell Proliferation. 2020 Sep 4 1
14 33045579 Implications of CD39 in immune-related diseases. 2020 Dec 1
15 33146056 Fully human anti-CD39 antibody potently inhibits ATPase activity in cancer cells via uncompetitive allosteric mechanism. 2020 Jan-Dec 1
16 33553158 Ectonucleotidase Modulation of Lymphocyte Function in Gut and Liver. 2020 1
17 29550257 Canonical and non-canonical adenosinergic pathways. 2019 Jan 1
18 31205451 HPV-16 Infection Is Associated with a High Content of CD39 and CD73 Ectonucleotidases in Cervical Samples from Patients with CIN-1. 2019 2
19 31379836 Purinergic Signaling in Pulmonary Inflammation. 2019 4
20 31652269 Monitoring and characterizing soluble and membrane-bound ectonucleotidases CD73 and CD39. 2019 2
21 31699796 Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity. 2019 Dec 2
22 29377887 Identification of allosteric inhibitors of the ecto-5'-nucleotidase (CD73) targeting the dimer interface. 2018 Jan 1
23 29455338 Extracellular ATP is Differentially Metabolized on Papillary Thyroid Carcinoma Cells Surface in Comparison to Normal Cells. 2018 Jun 2
24 29559470 Autocrine Adenosine Regulates Tumor Polyfunctional CD73+CD4+ Effector T Cells Devoid of Immune Checkpoints. 2018 Jul 1 1
25 30303204 Development of a selective and highly sensitive fluorescence assay for nucleoside triphosphate diphosphohydrolase1 (NTPDase1, CD39). 2018 Nov 5 4
26 30473700 ATP and Its Metabolite Adenosine as Regulators of Dendritic Cell Activity. 2018 1
27 27830476 Production of heterozygous alpha 1,3-galactosyltransferase (GGTA1) knock-out transgenic miniature pigs expressing human CD39. 2017 Apr 2
28 27862653 Reply: Adenosine Producing Mesenchymal Stromal Cells. 2017 Jun 2
29 28344879 Prostaglandin E2-mediated adenosinergic effects on CD14+ cells: Self-amplifying immunosuppression in cancer. 2017 1
30 28759073 Defective ATP breakdown activity related to an ENTPD1 gene mutation demonstrated using 31P NMR spectroscopy. 2017 Aug 10 3
31 29209319 Mesenchymal Stem Cells Induce Expression of CD73 in Human Monocytes In Vitro and in a Swine Model of Myocardial Infarction In Vivo. 2017 1
32 26328528 Activated-platelet targeting of CD39 as a potential way forward. The quest for efficient antithrombotic therapy without associated bleeding complications. 2016 1
33 26731338 Adenosinergic Immunosuppression by Human Mesenchymal Stromal Cells Requires Co-Operation with T cells. 2016 Mar 1
34 26787824 Regulatory T Cells from Colon Cancer Patients Inhibit Effector T-cell Migration through an Adenosine-Dependent Mechanism. 2016 Mar 1
35 27236363 Regulation of the T Cell Response by CD39. 2016 Jul 1
36 27906627 Oxidized low-density lipoproteins enhance expression and activity of CD39 and CD73 in the human aortic valve endothelium. 2016 Dec 3
37 25372046 Fluorescence polarization immunoassays for monitoring nucleoside triphosphate diphosphohydrolase (NTPDase) activity. 2015 Jan 7 2
38 25717146 Purinergic signaling modulates human visceral adipose inflammatory responses: implications in metabolically unhealthy obesity. 2015 May 1
39 25820525 Suppression of endothelial CD39/ENTPD1 is associated with pulmonary vascular remodeling in pulmonary arterial hypertension. 2015 May 15 1
40 25877509 Impaired natriuretic response to high-NaCl diet plus aldosterone infusion in mice overexpressing human CD39, an ectonucleotidase (NTPDase1). 2015 Jun 15 1
41 26059452 Beyond ecto-nucleotidase: CD39 defines human Th17 cells with CD161. 2015 Sep 1
42 24213679 Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression? 2014 Jan 1
43 24600452 The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ Transplantation. 2014 1
44 24749746 Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells. 2014 Aug 1
45 24844296 Extracellular ATP hydrolysis inhibits synaptic transmission by increasing ph buffering in the synaptic cleft. 2014 May 1
46 24940685 Functional analysis of expression of human ecto-nucleoside triphosphate diphosphohydrolase-1 and/or ecto-5'-nucleotidase in pig endothelial cells. 2014 8
47 25272186 Th2 cytokine-primed airway smooth muscle cells induce mast cell chemotaxis via secretion of ATP. 2014 Dec 1
48 25411844 Fingolimod increases CD39-expressing regulatory T cells in multiple sclerosis patients. 2014 1
49 23271562 Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go? 2013 Jun 1
50 23601906 CD39 and CD73 in immunity and inflammation. 2013 Jun 2